1615697-16-9

1615697-16-9 structure

Name: Lifastuzumab
Chemical Name: Lifastuzumab
CAS Number: 1615697-16-9
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Others
Create Date: 2023-11-26 06:05:43
Modify Date: 2024-09-17 18:38:13
Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity[1].

Name	Lifastuzumab

Description	Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity[1].
Related Catalog	Research Areas >> Others
References	[1]. Banerjee S, et al. Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study. Ann Oncol. 2018 Apr 1;29(4):917-923.

No Any Chemical & Physical Properties